TY - JOUR
T1 - Racial/Ethnic Disparities in Patients Undergoing Transcatheter Aortic Valve Replacement
T2 - Insights from the Healthcare Cost and Utilization Project's National Inpatient Sample
AU - Hernandez-Suarez, Dagmar F.
AU - Ranka, Sagar
AU - Villablanca, Pedro
AU - Yordan-Lopez, Nicole
AU - González-Sepúlveda, Lorena
AU - Wiley, Jose
AU - Sanina, Cristina
AU - Roche-Lima, Abiel
AU - Nieves-Rodriguez, Brenda G.
AU - Thomas, Stacey
AU - Cox-Alomar, Pedro
AU - Lopez-Candales, Angel
AU - Ramakrishna, Harish
N1 - Funding Information:
This study was funded by the National Institute of Health (NIH) Award Numbers U54MD007587, S21MD001830, R25MD007607 and TL1TR001434-3. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health. The authors declare no conflict of interest.
Funding Information:
This study was funded by the National Institute of Health (NIH) Award Numbers U54MD007587 , S21MD001830 , R25MD007607 and TL1TR001434-3 . Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health.
Publisher Copyright:
© 2019 Elsevier Inc.
PY - 2019/7
Y1 - 2019/7
N2 - Purpose: To identify racial/ethnic disparities in utilization rates, in-hospital outcomes and health care resource use among Non-Hispanic Whites (NHW), African Americans (AA) and Hispanics undergoing transcatheter aortic valve replacement (TAVR) in the United States (US). Methods and results: The National Inpatient Sample database was queried for patients ≥18 years of age who underwent TAVR from 2012 to 2014. The primary outcome was all-cause in hospital mortality. A total of 36,270 individuals were included in the study. The number of TAVR performed per million population increased in all study groups over the three years [38.8 to 103.8 (NHW); 9.1 to 26.4 (AA) and 9.4 to 18.2 (Hispanics)]. The overall in-hospital mortality was 4.2% for the entire cohort. Race/ethnicity showed no association with in-hospital mortality (P >.05). Though no significant difference were found between AA and NHW in any secondary outcome, being Hispanic was associated with higher incidence of acute myocardial infarction (aOR = 2.02; 95% CI, 1.06–3.85; P =.03), stroke/transient ischemic attack (aOR = 1.81; 95% CI, 1.04–3.14; P =.04), acute kidney injury (aOR = 1.65; 95% CI, 1.23–2.21; P <.01), prolonged length of stay (aOR = 1.18; 95% CI, 1.08–1.29; P <.01) and higher hospital costs (aOR = 1.27; 95% CI, 1.18–1.36; P <.01). Conclusion: There are significant racial disparities in patients undergoing TAVR in the US. Though in-hospital mortality was not associated with race/ethnicity, Hispanic patients had less TAVR utilization, higher in-hospital complications, prolonged length of stay and increased hospital costs.
AB - Purpose: To identify racial/ethnic disparities in utilization rates, in-hospital outcomes and health care resource use among Non-Hispanic Whites (NHW), African Americans (AA) and Hispanics undergoing transcatheter aortic valve replacement (TAVR) in the United States (US). Methods and results: The National Inpatient Sample database was queried for patients ≥18 years of age who underwent TAVR from 2012 to 2014. The primary outcome was all-cause in hospital mortality. A total of 36,270 individuals were included in the study. The number of TAVR performed per million population increased in all study groups over the three years [38.8 to 103.8 (NHW); 9.1 to 26.4 (AA) and 9.4 to 18.2 (Hispanics)]. The overall in-hospital mortality was 4.2% for the entire cohort. Race/ethnicity showed no association with in-hospital mortality (P >.05). Though no significant difference were found between AA and NHW in any secondary outcome, being Hispanic was associated with higher incidence of acute myocardial infarction (aOR = 2.02; 95% CI, 1.06–3.85; P =.03), stroke/transient ischemic attack (aOR = 1.81; 95% CI, 1.04–3.14; P =.04), acute kidney injury (aOR = 1.65; 95% CI, 1.23–2.21; P <.01), prolonged length of stay (aOR = 1.18; 95% CI, 1.08–1.29; P <.01) and higher hospital costs (aOR = 1.27; 95% CI, 1.18–1.36; P <.01). Conclusion: There are significant racial disparities in patients undergoing TAVR in the US. Though in-hospital mortality was not associated with race/ethnicity, Hispanic patients had less TAVR utilization, higher in-hospital complications, prolonged length of stay and increased hospital costs.
KW - Comparative outcomes
KW - Disparity
KW - Transcatheter aortic valve replacement
UR - http://www.scopus.com/inward/record.url?scp=85064160837&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85064160837&partnerID=8YFLogxK
U2 - 10.1016/j.carrev.2019.04.005
DO - 10.1016/j.carrev.2019.04.005
M3 - Article
C2 - 30987828
AN - SCOPUS:85064160837
SN - 1553-8389
VL - 20
SP - 546
EP - 552
JO - Cardiovascular Revascularization Medicine
JF - Cardiovascular Revascularization Medicine
IS - 7
ER -